The drug ibrutinib is used to treat certain types of cancer in cases where previous treatment regimens have failed, in addition, the drug is also used in the treatment of limiting rejection after a cell transplant. stem cells.

Brukinsa has the active ingredient zanubrutinib and is used to treat neuroblastoma. The drug is manufactured by BeiGene Company - China and is used under a doctor's prescription.

The drug Brukinsa has the active ingredient zanubrutinib, this is a drug used in the treatment of neuroblastoma very effectively. Breyanzi is currently licensed for use in many countries around the world.